Researchers from Karolinska Institutet and collaborators used particles in exhaled air to look for antibodies from the small airways. Their study, published in eBioMedicine on November 2, involved 28 people, including 18 who had recently experienced a respiratory infection.
Using paired samples from breath, blood and nasal secretions, the team detected IgA and IgG antibodies against SARS-CoV-2, influenza and respiratory syncytial virus. IgG patterns in the airway samples generally tracked with blood levels, while IgA showed a different pattern.
This was an initial methods study with a small group. The authors say larger studies are needed to validate the approach; it is a research method, not a proven clinical test.


